- Home
- BOSC vs BOLD Comparison
BOSC vs BOLD Comparison
Compare BOSC & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOSC
- BOLD
- Stock Information
- Founded
- BOSC 1990
- BOLD 2018
- Country
- BOSC Israel
- BOLD United States
- Employees
- BOSC N/A
- BOLD N/A
- Industry
- BOSC Computer Communications Equipment
- BOLD
- Sector
- BOSC Telecommunications
- BOLD
- Exchange
- BOSC Nasdaq
- BOLD Nasdaq
- Market Cap
- BOSC 29.5M
- BOLD 24.4M
- IPO Year
- BOSC 1996
- BOLD 2024
- Fundamental
- Price
- BOSC $4.91
- BOLD $1.19
- Analyst Decision
- BOSC
- BOLD Buy
- Analyst Count
- BOSC 0
- BOLD 3
- Target Price
- BOSC N/A
- BOLD $4.00
- AVG Volume (30 Days)
- BOSC 104.2K
- BOLD 105.1K
- Earning Date
- BOSC 08-21-2025
- BOLD 08-11-2025
- Dividend Yield
- BOSC N/A
- BOLD N/A
- EPS Growth
- BOSC 35.10
- BOLD N/A
- EPS
- BOSC 0.49
- BOLD N/A
- Revenue
- BOSC $43,688,000.00
- BOLD N/A
- Revenue This Year
- BOSC N/A
- BOLD N/A
- Revenue Next Year
- BOSC N/A
- BOLD N/A
- P/E Ratio
- BOSC $10.24
- BOLD N/A
- Revenue Growth
- BOSC 0.84
- BOLD N/A
- 52 Week Low
- BOSC $2.50
- BOLD $1.00
- 52 Week High
- BOSC $5.50
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- BOSC 49.50
- BOLD N/A
- Support Level
- BOSC $4.88
- BOLD N/A
- Resistance Level
- BOSC $5.10
- BOLD N/A
- Average True Range (ATR)
- BOSC 0.24
- BOLD 0.00
- MACD
- BOSC -0.04
- BOLD 0.00
- Stochastic Oscillator
- BOSC 31.34
- BOLD 0.00
About BOSC B.O.S. Better Online Solutions
BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.